Should Vanguard Small-Cap Growth ETF ( VBK ) Be on Your Investing Radar?
Style Box ETF report for ...
Cathie Wood Just Dropped $12.9 Million On This Trendy Robotaxi Stock, Ark Also Loads Up On Amazon Shares - Archer Aviation ( NYSE:ACHR ) , Amazon.com ( NASDAQ:AMZN )
On Tuesday, Cathie Wood-led Ark Invest made notable trades involving Amazon.com Inc. AMZN, Pony AI Inc. PONY, and Archer Aviation Inc. ACHR. These trades reflect Ark's strategic positioning in key sectors, including e-commerce, autonomous driving, and aviation technology.
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 10 years by 14.38% on an annualized basis producing an average annual return of 26.21%. Currently, Natera has a market capitalization of $21.93 billion.
SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday - Blue Gold ( NASDAQ:BGL ) , Astrana Health ( NASDAQ:ASTH )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Friday. Shares of SoundHound AI, Inc. SOUN rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates.
How Is The Market Feeling About Natera? - Natera ( NASDAQ:NTRA )
Natera's NTRA short percent of float has fallen 41.44% since its last report. The company recently reported that it has 3.72 million shares sold short, which is 2.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.71 days to cover their ...
Natera ( NTRA ) Reports Q2 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of -23.33% and +15.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Natera NTRA Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, August 7, 2025 at 4:30 p.m. ETChief Executive Officer - Steve ChapmanContinue reading ...
Natera ( NTRA ) Q2 Revenue Jumps 32%
Natera ( NASDAQ:NTRA ) , a leader in genetic testing across oncology, women's health, and organ health, reported its earnings for Q2 2025 on August 7, 2025. The most significant news was a 32.2% year-over-year revenue increase, rising to $546.6 million ( GAAP ) and outpacing analyst expectations ...
Pediatrix Medical Group ( MD ) Q2 Earnings and Revenues Top Estimates
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of +26.19% and +0.43%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
How Do Investors Really Feel About Natera? - Natera ( NASDAQ:NTRA )
Natera's NTRA short percent of float has fallen 41.44% since its last report. The company recently reported that it has 3.72 million shares sold short, which is 2.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.71 days to cover their ...
Medpace ( MEDP ) Q2 Earnings and Revenues Surpass Estimates
Medpace (MEDP) delivered earnings and revenue surprises of +3.33% and +11.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 5 years by 10.73% on an annualized basis producing an average annual return of 24.64%. Currently, Natera has a market capitalization of $20.46 billion.
Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release
TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
Here's How Much $100 Invested In Natera 10 Years Ago Would Be Worth Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 10 years by 10.88% on an annualized basis producing an average annual return of 22.3%. Currently, Natera has a market capitalization of $22.96 billion.
Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 10 years by 11.22% on an annualized basis producing an average annual return of 22.09%. Currently, Natera has a market capitalization of $22.58 billion.
Should Vanguard Small-Cap Growth ETF ( VBK ) Be on Your Investing Radar?
Style Box ETF report for ...
Should You Invest in the Invesco Biotechnology & Genome ETF ( PBE ) ?
Sector ETF report for ...
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 5 years by 14.71% on an annualized basis producing an average annual return of 28.45%. Currently, Natera has a market capitalization of $20.94 billion.
Is Invesco Biotechnology & Genome ETF ( PBE ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 5 years by 13.02% on an annualized basis producing an average annual return of 28.31%. Currently, Natera has a market capitalization of $21.48 billion.
Natera ( NTRA ) Reports Q1 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of 15.25% and 13.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Enhabit ( EHAB ) Q1 Earnings Top Estimates
Enhabit (EHAB) delivered earnings and revenue surprises of 42.86% and 2.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Pediatrix Medical Group ( MD ) Q1 Earnings and Revenues Surpass Estimates
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of 32% and 0.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Peering Into Natera's Recent Short Interest - Natera ( NASDAQ:NTRA )
Natera's NTRA short percent of float has risen 7.64% since its last report. The company recently reported that it has 6.01 million shares sold short, which is 4.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.4 days to cover their ...
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 5 years by 20.08% on an annualized basis producing an average annual return of 34.44%. Currently, Natera has a market capitalization of $20.69 billion.
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 5 years by 19.34% on an annualized basis producing an average annual return of 33.37%. Currently, Natera has a market capitalization of $20.02 billion.
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
Stanley Druckenmiller is in an elite league of investors that includes the likes of Warren Buffett. He ran his hedge fund firm, Duquesne Capital Management, for 30 years, posting eye-popping average annual returns of 30%.
Is the Market Bullish or Bearish on Natera? - Natera ( NASDAQ:NTRA )
Natera's NTRA short percent of float has risen 33.63% since its last report. The company recently reported that it has 3.85 million shares sold short, which is 2.98% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.63 days to cover their ...
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Oncocyte Reports Successful 2024. Sets Stage for 2025 Catalysts ...
Is Invesco Biotechnology & Genome ETF ( PBE ) a Strong ETF Right Now?
Smart Beta ETF report for ...
How Do Investors Really Feel About Natera? - Natera ( NASDAQ:NTRA )
Natera's NTRA short percent of float has fallen 44.35% since its last report. The company recently reported that it has 2.49 million shares sold short, which is 1.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.11 days to cover their ...
Natera ( NTRA ) Reports Q4 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of 2.38% and 0.88%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock?
XRAY is likely to have faced a tough fourth quarter with Byte's revenue loss, weak U.S. equipment demand and implant pressures.
Is Gilead Sciences ( GILD ) Outperforming Other Medical Stocks This Year?
Here is how Gilead Sciences (GILD) and Natera (NTRA) have performed compared to their sector so far this year.
Stanley Druckenmiller Ditches Broadcom, Ups Ante On Big Tech Including Tesla - Autodesk ( NASDAQ:ADSK ) , Adobe ( NASDAQ:ADBE )
Billionaire investor Stanley Druckenmiller's family office Duquesne has divested his entire stake in Broadcom, simultaneously increasing his investments in major tech companies, as revealed in a recent 13-F filing.
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 5 years by 23.29% on an annualized basis producing an average annual return of 36.12%. Currently, Natera has a market capitalization of $23.24 billion.
HSIC Gears Up for Q4 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.
Natera ( NTRA ) Recently Broke Out Above the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will BAX's Q4 Earnings Reflect Its Efforts to Counter Headwinds?
Baxter might have faced fourth-quarter hurdles from Hurricane Helene. However, it expects growth in infusion therapies, pharmaceuticals and patient support systems to have driven recovery.
DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact?
DexCom Q4 results are likely to reflect strong growth on the back of U.S. sales expansion, global gains and Stelo traction, driving momentum and market expansion into 2025.
GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness?
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma is likely to have been the key driver.
Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings?
West Pharmaceutical Services eyes fourth-quarter growth amid pharma stabilization, biologics rebound & contract manufacturing gains. Can WST sustain its momentum?
Should You Invest in the First Trust NYSE Arca Biotechnology ETF ( FBT ) ?
Sector ETF report for ...
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today - Natera ( NASDAQ:NTRA )
Natera NTRA has outperformed the market over the past 5 years by 25.51% on an annualized basis producing an average annual return of 38.05%. Currently, Natera has a market capitalization of $23.14 billion.
Molina Healthcare to Report Q4 Earnings: What Do the Estimates Say?
MOH's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
MCK Stock Before Q3 Earnings: A Smart Buy or Risky Investment?
McKesson's third-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
Cencora to Report Q1 Earnings: Is a Beat Likely for the Stock?
COR's fiscal first-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
Is First Trust Health Care AlphaDEX ETF ( FXH ) a Strong ETF Right Now?
Smart Beta ETF report for ...
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
